» Articles » PMID: 8583565

Fertility Potential After Unilateral Orchiopexy: Simultaneous Testicular Biopsy and Orchiopexy in a Cohort of 87 Patients

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1996 Mar 1
PMID 8583565
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We investigated the prognostic value of the number of spermatogonia per tubular cross section in a testicular biopsy specimen obtained at orchiopexy for unilateral cryptorchidism.

Materials And Methods: A total of 87 consecutive 10 to 12-year-old cryptorchid boys underwent testicular biopsy simultaneously with unilateral orchiopexy. In adulthood 56 of the 87 patients agreed to measurement of serum follicle-stimulating hormone, luteinizing hormone, testosterone and testicular volume, and 54 provided specimens for semen analysis.

Results: The number of spermatogonia per tubular cross section correlated to the volume of the operated testis and total testicular volume in adulthood. Serum follicle-stimulating hormone negatively correlated to these volumes, sperm concentration and total sperm count. Contralateral testicular volume correlated to sperm concentration, total sperm count, and percent of living and mobile sperm. When biopsy revealed Sertoli cells only or 1 spermatogonium per 100 tubular cross sections, the age matched number of spermatogonia per tubular cross section was 1% or less. Of these patients 33% later presented with 5 million spermatozoa per ml. or less, no normal motility and generally lower sperm concentrations that those with more than 1 spermatogonium per 100 tubular cross sections (greater than 1%) in the biopsy specimen. When the value was greater than 1%, later sperm quality was not significantly reduced in comparison to that of the general population.

Conclusions: The age matched number of spermatogonia per tubular cross section is significant in regard to fertility potential, and a value of 1% or less (approximately Sertoli cells only) may predict low fertility potential. To our knowledge Sertoli cells only have not been observed before 15 months of life, which makes it logical to treat cryptorchidism before this age even in unilateral cases.

Citing Articles

Long-term outcomes of erectile function in adult orchidopexy patients.

Ghanem M, Adawi E, Ghanem A, Ghanem A Asian J Urol. 2024; 11(4):642-650.

PMID: 39533990 PMC: 11551369. DOI: 10.1016/j.ajur.2024.02.001.


Cryptorchidism and puberty.

Rodprasert W, Virtanen H, Toppari J Front Endocrinol (Lausanne). 2024; 15:1347435.

PMID: 38532895 PMC: 10963523. DOI: 10.3389/fendo.2024.1347435.


Surgical treatment of cryptorchidism: current insights and future directions.

Pakkasjarvi N, Taskinen S Front Endocrinol (Lausanne). 2024; 15:1327957.

PMID: 38495791 PMC: 10940471. DOI: 10.3389/fendo.2024.1327957.


Testicular Surveillance Post-Orchidopexy and its Impact on Early Diagnosis of Testicular Cancer.

Mohamed A, Murtagh K, Kockelbergh R, ElMalik K Indian J Surg Oncol. 2020; 11(3):513-517.

PMID: 33013137 PMC: 7501319. DOI: 10.1007/s13193-020-01169-5.


Germ cell development in the descended and cryptorchid testis and the effects of hormonal manipulation.

Ong C, Hasthorpe S, Hutson J Pediatr Surg Int. 2005; 21(4):240-54.

PMID: 15726388 DOI: 10.1007/s00383-005-1382-0.